Holding(s) in Company

RNS Number : 3775C

e-Therapeutics plc

11 November 2009

 



e-Therapeutics plc

Holdings in Company

e-Therapeutics plc (the "Company") (AIM:ETX) received notification on 11 November 2009 that pursuant to the placing announced on 2 November, Gartmore Investment Limited holds 6,541,000 ordinary shares representing approximately 9.998% of the issued share capital of the Company.

The Company has 65,420,292 ordinary shares with a nominal value of 0.1p with voting rights in issue, none of which are held in treasury.

For more information:
e-Therapeutics plc	www.etherapeutics.co.uk
Malcolm Young [e-mail]	[phone]
Nominated Advisor & Broker: Canaccord Adams Ltd	www.canaccordadams.com
Robert Finlay Henry Fitzgerald-O'Connor	[phone]

 

END

 

 

HOLEAXFFFLLNFFE